Endosomal dysfunction in iPSC-derived neural cells from Parkinson's disease patients with VPS35 D620N
Keiko Bono1,2, Chikako Hara-Miyauchi1, Shunsuke Sumi1
1Division of Regenerative Medicine, The Jikei University School of Medicine, 3-25-8 Nishi-Shimbashi, Minato-ku, Tokyo, 105-8461, Japan.
Abstract:
Mutations in the Vacuolar protein sorting 35 (VPS35) gene have been linked to familial Parkinson's disease (PD), PARK17. VPS35 is a key component of the retromer complex, which plays a central role in endosomal trafficking. However, whether and how VPS35 deficiency or mutation contributes to PD pathogenesis remain unclear. Here, we analyzed human induced pluripotent stem cell (iPSC)-derived neurons from PD patients with the VPS35 D620N mutation and addressed relevant disease mechanisms. In the disease group, dopaminergic (DA) neurons underwent extensive apoptotic cell death. The movement of Rab5a- or Rab7a-positive endosomes was slower, and the endosome fission and fusion frequencies were lower in the PD group than in the healthy control group. Interestingly, vesicles positive for cation-independent mannose 6-phosphate receptor transported by retromers were abnormally localized in glial cells derived from patient iPSCs. Furthermore, we found α-synuclein accumulation in TH positive DA neurons. Our results demonstrate the induction of cell death, endosomal dysfunction and α -synuclein accumulation in neural cells of the PD group. PARK17 patient-derived iPSCs provide an excellent experimental tool for understanding the pathophysiology underlying PD.
Insights
Mutations in the Vacuolar protein sorting 35 (VPS35) gene cause Parkinson's disease (PD) by impairing endosomal trafficking and leading to neuronal cell death and alpha-synuclein accumulation.
Area of Science:
- Neuroscience
- Genetics
- Cell Biology
Background:
- Vacuolar protein sorting 35 (VPS35) mutations are linked to familial Parkinson's disease (PD), designated PARK17.
- VPS35 is crucial for the retromer complex, essential for endosomal trafficking.
- The precise role of VPS35 dysfunction in PD pathogenesis remains to be fully elucidated.
Purpose of the Study:
- To investigate the cellular mechanisms underlying PD in patients with the VPS35 D620N mutation.
- To analyze neuronal and glial cells derived from patient-specific induced pluripotent stem cells (iPSCs).
Main Methods:
- Utilized human induced pluripotent stem cell (iPSC)-derived neurons and glial cells from PD patients carrying the VPS35 D620N mutation.
- Assessed dopaminergic (DA) neuron viability, endosomal trafficking dynamics (Rab5a, Rab7a), and vesicle localization.
- Investigated alpha-synuclein aggregation in DA neurons.
Main Results:
- PD patient-derived neurons exhibited significant apoptotic cell death.
- Endosomal trafficking was impaired, characterized by slower movement and reduced fission/fusion of Rab5a/Rab7a-positive endosomes.
- Abnormal retromer-dependent vesicle localization was observed in glial cells, and alpha-synuclein accumulated in TH-positive DA neurons.
Conclusions:
- VPS35 D620N mutation induces dopaminergic neuron death, endosomal dysfunction, and alpha-synuclein accumulation.
- Patient-derived iPSCs offer a valuable model for studying PARK17-associated PD pathophysiology.
- This study highlights the critical role of VPS35 in maintaining neuronal health and endosomal integrity in Parkinson's disease.
More Related Videos
09:21Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons
Published on: July 7, 2023
15:09The Use of Primary Human Fibroblasts for Monitoring Mitochondrial Phenotypes in the Field of Parkinson's Disease
Published on: October 3, 2012
Related Concept Videos
EPS and iPS Cells in Disease Research
iPS Cell Differentiation
Lysosomal Hydrolases
Parkinson's Disease: Overview
Neural Regulation
